Stock Report

Download full stock data and analysis for free Last Updated: 07-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Novo Nordisk A/S - ADR Key Ratios

Stock Card factsheet share-fund-plan-icon

$46.60

up-down-arrow $-0.91 (-1.92%)

As on 04-Sep-2026 19:58EDT

Market cap

info icon

$210,043 Mln

Revenue (TTM)

info icon

$329,431 Mln

P/E Ratio

info icon

11.6

P/B Ratio

info icon

5.8

Div. Yield

info icon

3.8 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -18.94 2.12 5.61 17.84 20.45
EBIT -56.79 -26.80 -1.97 24.11 22.86
Net Profit -56.77 -20.81 4.84 20.09 21.29
EPS -56.65 -20.61 5.02 20.73 22.33
Book Value -- -- 35.62 33.20 81.16
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-25Dec-24
EBIT-Margin info 44.4242.9346.6743.6044.36
Net Margin info ----35.35----
Return on equity info 76.5183.8556.0760.7080.78
Return on Capital info 52.6559.78--35.8653.17
Return on Assets info 25.4429.1115.2820.3125.89
Debt to Equity (x) info ----0.550.670.72

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Novo Nordisk A/S - ADR
--
35.86
53.17
68.92
53.74
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

56.07

Higher than Peers by 37.10

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Novo Nordisk A/S - ADR
56.07
60.70
80.78
88.07
72.00
Peer Median
18.97
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

15.28

Higher than Peers by 12.43

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Novo Nordisk A/S - ADR
15.28
20.31
25.89
30.12
25.48
Peer Median
2.86
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

46.67

Higher than Peers by 30.85

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Novo Nordisk A/S - ADR
46.67
43.60
44.36
45.30
39.24
Peer Median
15.82
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

35.35

Higher than Peers by 27.11

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Novo Nordisk A/S - ADR
35.35
33.14
34.78
36.03
31.38
Peer Median
8.23
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Novo Nordisk A/S - ADR
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

5.61

Lower than Peers by 2.44

Year on year growth in net sales

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Novo Nordisk A/S - ADR
5.61
0.06
0.25
0.31
0.26
Peer Median
8.05
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-1.97

Lower than Peers by 10.23

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Novo Nordisk A/S - ADR
-1.97
4.59
22.44
51.52
16.96
Peer Median
8.26
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

4.84

Lower than Peers by 2.89

Year on year growth in profit after tax

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Novo Nordisk A/S - ADR
4.84
1.43
20.68
50.71
16.27
Peer Median
7.73
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

5.02

Lower than Peers by 5.37

Year on year growth in earnings per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Novo Nordisk A/S - ADR
5.02
0.02
0.21
0.52
0.18
Peer Median
10.39
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

31.99

Higher than Peers by 27.11

Year on year growth in book value per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Novo Nordisk A/S - ADR
31.99
--
--
--
--
Peer Median
4.87
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

0.55

Lower than Peers by 0.05

Total debt / Net worth

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Novo Nordisk A/S - ADR
0.55
0.67
0.72
0.25
0.31
Peer Median
0.60
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

0.08

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Novo Nordisk A/S - ADR
0.08
0.06
0.09
0.06
0.02
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

0.87

Lower than Peers by 0.78

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Novo Nordisk A/S - ADR
0.87
0.80
0.74
0.82
0.89
Peer Median
1.65
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

0.66

Lower than Peers by 0.54

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Novo Nordisk A/S - ADR
0.66
0.57
0.55
0.64
0.69
Peer Median
1.20
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

8.98

Higher than Peers by 4.21

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Novo Nordisk A/S - ADR
8.98
32.03
78.56
194.13
183.70
Peer Median
4.77
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

32.94

Higher than Peers by 11.67

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Novo Nordisk A/S - ADR
32.94
24.49
30.10
32.40
32.50
Peer Median
21.27
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.43

Higher than Peers by 0.03

Sales / Average Total Assets

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Novo Nordisk A/S - ADR
0.43
0.61
0.74
0.84
0.81
Peer Median
0.40
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Novo Nordisk A/S - ADR
--
96.38
102.30
104.39
107.65
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Novo Nordisk A/S - ADR
--
281.05
298.04
286.97
282.52
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Novo Nordisk A/S - ADR
--
150.99
223.36
210.34
157.00
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Novo Nordisk A/S - ADR
--
226.45
176.99
181.02
233.16
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...